Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Testing effectiveness (Phase 2)Study completedNCT00096499
What this trial is testing

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT00736164
What this trial is testing

Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Testing effectiveness (Phase 2)Study completedNCT00006365
What this trial is testing

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 138
Testing effectiveness (Phase 2)Looking for participantsNCT05616650
What this trial is testing

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Who this might be right for
Prostatic NeoplasmsProstate CancerProstate Adenocarcinoma
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)WithdrawnNCT01859689
What this trial is testing

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00038168
What this trial is testing

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT00005039
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)UnknownNCT00002775
What this trial is testing

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Herbert Irving Comprehensive Cancer Center 37
Early research (Phase 1)Study completedNCT00459407
What this trial is testing

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00466752
What this trial is testing

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer
University of Washington 5
Testing effectiveness (Phase 2)Study completedNCT00244998
What this trial is testing

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 20
Early research (Phase 1)Ended earlyNCT00788307
What this trial is testing

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Early research (Phase 1)Study completedNCT00482807
What this trial is testing

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 9
Not applicableActive Not RecruitingNCT00769223
What this trial is testing

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostate CancerRadiation Toxicity
University of California, San Francisco 3,561
Early research (Phase 1)Study completedNCT01912820
What this trial is testing

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+4 more
Jonsson Comprehensive Cancer Center 32
Not applicableEnded earlyNCT00379119
What this trial is testing

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 20
Testing effectiveness (Phase 2)Looking for participantsNCT05726292
What this trial is testing

Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Chicago 90
Next Page